Ubs Group Ag Okyo Pharma LTD Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$1.69 - $2.7 $10,716 - $17,120
6,341 Added 536.46%
7,523 $14,000
Q3 2022

Nov 10, 2022
SELL
$1.95 - $3.4 $4,845 - $8,449
-2,485 Reduced 67.77%
1,182 $3,000
Q2 2022

Aug 10, 2022
BUY
$1.92 - $3.62 $7,040 - $13,274
3,667 New
3,667 $8,000

About OKYO Pharma Ltd

OKYO Quotes by TradingView
  • Ticker OKYO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,144,900
  • Market Cap $23.9M
  • Description
  • OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide pre...
More about OKYO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email